Skip to main content
Clinical Trials/NCT06008444
NCT06008444
Completed
N/A

Chest Mobility, Cough Strength, Muscle Strength, Physical Activity and Quality of Life in Parkinson's Patients Who Have Had COVID-19

Izmir Democracy University1 site in 1 country32 target enrollmentMay 13, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
COVID-19 Respiratory Infection
Sponsor
Izmir Democracy University
Enrollment
32
Locations
1
Primary Endpoint
Total quality of life score evaluated by Parkinson's Disease Questionnaire (PDQ-39) questionnaire.
Status
Completed
Last Updated
11 months ago

Overview

Brief Summary

To comparative pain intensity, chest mobility, cough strength, muscle strength, physical activity levels and quality of life in Parkinson's patients with post-COVID-19 and without post-COVID-19 was aimed in current study. Knowledge in the literature regarding this topic is still obscure.

Detailed Description

Acute worsening and long-term sequelae of motor and non-motor symptoms have also been described in Parkinson's patients during and after SARS-CoV-2 infection, which is also known as prolonged COVID. The effects of COVID-19 on pain, chest mobility, cough strength, muscle strength, physical activity levels and quality of life in Parkinson's patients are still unclear today. For this reason, in this study, it was aimed to comparatively investigate pain, chest mobility, cough strength, muscle strength, physical activity levels and quality of life in Parkinson's patients with COVID-19 and without COVID-19 and to show the relationships between these outcome measures.

Registry
clinicaltrials.gov
Start Date
May 13, 2023
End Date
December 30, 2024
Last Updated
11 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Izmir Democracy University
Responsible Party
Principal Investigator
Principal Investigator

Gulsah Bargi

Principal Investigator

Izmir Democracy University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Total quality of life score evaluated by Parkinson's Disease Questionnaire (PDQ-39) questionnaire.

Time Frame: through study completion, an average of 1 year

The status of quality of life will be evaluated using Parkinson's Disease Questionnaire (PDQ-39) questionnaire. Parkinson's Disease Questionnaire-39 (PDQ39) is a 39-item quality of life questionnaire. Evaluation for each question item ranges from 0 (no problem) to 4 (constant problem). Low scores in total indicate an improvement in people's quality of life.

Secondary Outcomes

  • Chest mobility(through study completion, an average of 1 year)
  • Cough Strength(through study completion, an average of 1 year)
  • Daily average step count(through study completion, an average of 1 year)
  • Hand grip strength(through study completion, an average of 1 year)
  • Cognitive status(through study completion, an average of 1 year)

Study Sites (1)

Loading locations...

Similar Trials